Corex-D – The Law Today Pakistan

Editor, Pfizer’s Assets Acquisition, CCP Grants Approval, Competition Commission of Pakistan, Pfizer Pakistan Limited, Lucky Core Industries, Frame Agreement, Asset Purchase Agreements, pharmaceutical products, Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D, Mycitracin, Pakistan pharmaceutical market, horizontal merger, market assessment, technological advancement, innovation, competitive market, fair competition, consumer benefits, industry growth, investment in pharmaceuticals

Pfizer’s Assets Acquisition, CCP Grants Approval

Estimated read time 2 min read
August 4, 2024

Lucky Core Industries, a publicly listed company in Pakistan, is engaged in manufacturing various chemicals and pharmaceuticals.